Innovation Capabilities & Products
- Patent | Myticin peptide and its use in cell regeneration
Authors: Antonio Figueras Huerta, María Gasset Vega, Beatriz Novoa García, Magalí Rey Campos, Ricardo Mallavía Marín, Regla María Medina Gali, Alicia Martínez López
The present invention relates to peptides derived from myticin C and to their therapeutic use, more specifically in cell and/or tissue regeneration. More detailed information can be obtained here.
- Patent | Andrographolide derivatives for their use in the treatment of cytokine-related inflammatory diseases
Authors: Eva María Rivero Buceta; Cristian Smerdou Picazo; Pablo Botella Asunción; Antonio Pineda Lucena; Carla María Vidaurre Agut; Beatriz Novoa; Antonio Figueras Huertas; Jose María Benlloch Baviera
Andrographolide derivatives for their use in the treatment of cytokine-related inflammatory diseases . Patent pending publication.
- Patent | Andrographolide derivatives for their use in the treatment of COVID-19 and associated pulmonary fibrosis
Authors: Antonio Pineda Lucena; Carla María Vidaurre Agut; Eva María Rivero Buceta; Jose María Benlloch Baviera; Cristian Smerdou Picazo; Beatriz Novoa; Antonio Figueras Huertas; Pablo Botella Asunción
Andrographolid derivatives for their use in the treatment of COVID-19 and associated pulmonary fibrosis. Patent pending publication.
- Patent | Method for the identification of antimicrobial polypeptides in Mytilus edulis
Authors: María del Mar Costa Portela, Beatriz Novoa García, Antonio Figueras Huerta, Sonia Dios Vidal, Camino Gestal Mateo
The invention provides a method for the identification of polynucleotides, coding precursors of polypeptides, with antibacterial and antiviral activity (myticines and mytilines). More detailed information can be obtained here.
- Capabilities | Development of “in vitro” bioactivity tests for biomolecules using cell lines and specific gene expression tests
Development of techniques (metabolomics, proteomics, genomics, lipidomics, biomarkers) to characterize the response of cells to different biomolecules and to validate their activity and safety.
- Capabilities | Pathogen incidence and risk assessment
Pathogen detection and identification in wild and farmed animals, as well as in seafood products. Evaluation of the relationship between pathogen incidence and various environmental and physiological aspects to provide risk assessments for target pathogens.
- Capabilities | Development of management and decision-making tools based on modeling and simulated scenariosCoastal & Environmental Protection Maritime Spatial Planning Ecosystem Services & Governance Aquaculture Fisheries
Development of space-specific tools for assessment, management and decision-making by modeling the impacts of present and possible future environmental scenarios (pollution, climate change, etc.) on oceanographic conditions, biodiversity distribution, physiological response or fisheries and aquaculture performance.
- Capabilities | Development of pathogen-resistant variants for aquaculture
Application of the most advanced -omic techniques for the identification of resistance genes that can be used as biomarkers for the selection of pathogen-resistant variants of marine aquaculture species.
- Capabilities | Development and optimization of aquaculture systems for traditional and new farmed species
Development of integrated culture techniques for new aquaculture species, as well as optimization of traditional ones based on different approaches (i.e. early development, handling, feeding, disease and immune responses, ecophysiological performance, or ecosystem carrying capacity) to improve animal welfare, yield and sustainability in global marine aquaculture.
- Capabilities | Development of immunostimulants and vaccines for aquaculture species
Application of the most advanced -omic techniques, together with immunology, microbiology and protein biochemistry, to develop immunostimulants and vaccines for aquaculture species.